Rheumatology, New York Presbyterian Hospital-Brooklyn Methodist Hospital, Brooklyn, NY, USA.
NYU Langone Medical Center, New York, NY, USA.
Rheumatol Int. 2018 Jan;38(1):3-11. doi: 10.1007/s00296-017-3820-4. Epub 2017 Sep 23.
Tumor necrosis factor-associated periodic syndrome is an autoinflammatory disorder classified under hereditary periodic fever syndromes. Mutations in the tumor necrosis factor receptor contribute to tumor necrosis factor-associated periodic syndrome. Decreased shedding of receptors and increased mitochondrial reactive oxygen species production leading to elevated proinflammatory cytokines are documented. Inflammation in various organs is hallmark of tumor necrosis factor-associated periodic syndrome and manifests as spiking fever, abdominal pain, conjunctivitis and polyserositis in adults. The ongoing challenge is to diagnose the disease early in its course to prevent amyloidosis. The treatment options have evolved from use of nonsteroidal anti-inflammatory drugs and corticosteroids to targeted therapy like tumor necrosis factor receptor inhibitors and interleukin-1 blockers. The aim of this review is to give an overview of the pathogenesis, clinical features and the various treatment modalities available for tumor necrosis factor-associated periodic syndrome and aid physicians in recognizing the signs of the disease earlier.
肿瘤坏死因子相关周期性综合征是一种自身炎症性疾病,归类于遗传性周期性发热综合征。肿瘤坏死因子受体的突变导致肿瘤坏死因子相关周期性综合征。已有文献记录受体脱落减少和线粒体活性氧物质产生增加导致促炎细胞因子水平升高。肿瘤坏死因子相关周期性综合征的特征是各种器官的炎症,表现为成人突发高热、腹痛、结膜炎和多发性浆膜炎。目前的挑战是在疾病早期诊断,以预防淀粉样变性。治疗选择已从非甾体抗炎药和皮质类固醇发展到靶向治疗,如肿瘤坏死因子受体抑制剂和白细胞介素-1 阻滞剂。本文旨在概述肿瘤坏死因子相关周期性综合征的发病机制、临床特征和各种治疗方法,帮助医生更早地识别疾病的迹象。